H. Lawrence (Larry) Culp, Jr., is the Chairman and Chief Executive Officer of GE and Chief Executive Officer of GE Aerospace. Larry is GE’s twelfth CEO and eleventh Chairman. He joined the GE Board of Directors in April 2018 and was appointed CEO of GE in October 2018. In June 2022, he was appointed CEO of GE Aerospace. As CEO, Larry has led GE’s transformation to become a more focused, simpler, and stronger high-tech industrial company.
Under his leadership, GE’s total gross debt reduction will be more than $90 billion through 2022. He has championed lean, bringing a focus on customer value, driving improvements in safety, quality, delivery, and cost, and running the company closer to the customer by creating nearly thirty P&Ls to increase operational visibility. Larry has also led the transformation of GE’s portfolio, including the sales of GE Capital Aviation Services (GECAS), Lighting, BioPharma, and the completion of the spin of GE Transportation along with its subsequent merger with Wabtec.
In November 2021, GE announced its plan to form three industry-leading, global public companies focused on the high-growth sectors of aviation, healthcare and energy. Larry will serve as non-executive chairman of the GE healthcare company upon its expected spin-off in early 2023. He will continue to serve as chairman and CEO of GE and CEO of GE Aerospace until the spin-off of the combined GE Renewable Energy and Power businesses, at which point, he will lead the GE aviation-focused company going forward.
Prior to joining GE, Larry served as the President and CEO of Danaher Corporation from 2001 to 2014, and during his tenure the company increased both its revenues and its market capitalization five-fold. Investors and analysts consistently ranked him as one of the top CEOs in annual Institutional Investor surveys, and Harvard Business Review named Larry one of the Top 50 CEOs in the world.
Larry joined Danaher in 1990 at Veeder-Root, becoming Presidentin 1993. He was appointed Group Executive and Corporate Officer in 1995, with responsibility for Danaher’s Environmental and Electronic Test and Measurement platforms while also serving as President of Fluke and Fluke Networks. He was named Executive VicePresident in 1999, Chief Operating Officer in 2001, and President and CEO in 2001.
Larry is a member and the immediate past chair of the Board of Visitors and Governors of his alma mater, Washington College, and also serves on the Wake Forest University Board of Trustees. Previously, Larry was a Senior Lecturer at Harvard Business School, where he focused on leadership, strategy and general management in the MBA and executive education programs.
A member of Phi Beta Kappa, Larry earned a B.A. in Economics from Washington College and an MBA from Harvard Business School.
What is H. Lawrence Culp, Jr.'s net worth?
The estimated net worth of H. Lawrence Culp, Jr. is at least $100,373.52 as of January 23rd, 2023. Mr. Culp, Jr. owns 1,272 shares of GE HealthCare Technologies stock worth more than $100,374 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Culp, Jr. may own. Learn More about H. Lawrence Culp, Jr.'s net worth.
How do I contact H. Lawrence Culp, Jr.?
Has H. Lawrence Culp, Jr. been buying or selling shares of GE HealthCare Technologies?
H. Lawrence Culp, Jr. has not been actively trading shares of GE HealthCare Technologies over the course of the past ninety days. Most recently, on Monday, January 23rd, H Lawrence Culp, Jr. bought 748 shares of GE HealthCare Technologies stock. The stock was acquired at an average cost of $69.26 per share, with a total value of $51,806.48. Following the completion of the transaction, the director now directly owns 1,272 shares of the company's stock, valued at $88,098.72. Learn More on H. Lawrence Culp, Jr.'s trading history.
Who are GE HealthCare Technologies' active insiders?
Are insiders buying or selling shares of GE HealthCare Technologies?
In the last year, GE HealthCare Technologies insiders bought shares 1 times. They purchased a total of 1,315 shares worth more than $100,623.80. In the last year, insiders at the sold shares 5 times. They sold a total of 96,809 shares worth more than $7,900,621.05. The most recent insider tranaction occured on November, 6th when CEO Roland Rott sold 3,577 shares worth more than $309,338.96. Insiders at GE HealthCare Technologies own 0.3% of the company.
Learn More about insider trades at GE HealthCare Technologies. Information on this page was last updated on 11/6/2024.
